Preliminary validation of a structural magnetic resonance imaging metric for tracking dementia-related neurodegeneration and future decline

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and atrophy in the medial temporal lobe (MTL) and subsequent brain regions. Structural magnetic resonance imaging (sMRI) has been widely used in research and clinical care for diagnosis and monitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kress, Gavin T., Popa, Emily S., Thompson, Paul M., Bookheimer, Susan Y., Thomopoulos, Sophia I., Ching, Christopher R.K., Zheng, Hong, Hirsh, Daniel A., Merrill, David A., Panos, Stella E., Raji, Cyrus A., Siddarth, Prabha, Bramen, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338152/
https://www.ncbi.nlm.nih.gov/pubmed/37421927
http://dx.doi.org/10.1016/j.nicl.2023.103458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338152/
https://www.ncbi.nlm.nih.gov/pubmed/37421927
http://dx.doi.org/10.1016/j.nicl.2023.103458

Ejemplares similares